Morning Wrap Today’s Newsflow Select headline to navigate to article Dragon Oil Q3 IMS - Rising cash pile, despite higher capex Equity Research 14 Oct 2014 Upcoming Events Company Events 14-Oct Economic View Modestly expansionary budget likely to be announced today 16-Oct UK Economic View BRC retail sales disappoint in September 17-Oct 21-Oct Bellway; Q4 2014 Results SABMiller; Q2 2015 Results Bwin.Party; Q3 2014 Results Diageo; Q1 2015 Results Iluka Resources; Q3 2014 Results - Production Report Mondi; Q3 2014 Results Syngenta; Q3 2014 Results Travis Perkins; Q3 2014 IMS William Hill; Q3 2014 Results PetroNeft Update on Drilling activity Builders Merchants Carpetright / Bellway point to robust activity levels in the UK Wolseley Kesko highlights difficult markets in Finland SIG Further disposal of non-core assets C & C Group SABMiller sees Europe weaker in Q2 CPL Resources Positive trends in Morgan McKinley employment monitor Economic Events Ireland 14-Oct Budget 2015 United Kingdom 14-Oct BRC Sales Like for like YoY Sep CPI YoY Sep 15-Oct ILO Unemployment Rate 3 mths Aug United States 15-Oct US Fed Release Beige Book Retail Sales Advance MoM Sep Empire Manufacturing Oct 17-Oct Univ of Michigan Confidence Oct Europe 14-Oct 16-Oct ZEW Survey Expectations Oct CPI YoY Sep Goodbody Capital Markets Equity Research +353 1 6419221 Equity Sales +353 1 6670222 Bloomberg GDSE<GO> Goodbody Stockbrokers (trading as Goodbody) is regulated by the Central Bank of Ireland. For the attention of US clients of Goodbody Securities Inc, this third-party research report has been produced by our affiliate Goodbody Stockbrokers. Please see the end of this report for analyst certifications and other important disclosures. Goodbody Morning Wrap Dragon Oil Q3 IMS - Rising cash pile, despite higher capex With average production for Q3 and September (80.5 kbopd and 82.5 kbopd respectively) previously outlined on October 10th, the focus of attention in the Dragon Oil IMS this morning largely relates to commentary regarding capex, the Q3 net cash position, the enhanced recovery programme and marketing. Cash balance, net of abandonment liabilities, amounted to $1.9bn as of September, relative to the $1.8bn recorded in June and our year-end target of $2.0bn ($2.7bn gross expectation). Q3 net entitlement of 55%, relative to 52% in H1 and an annual estimate in our model of 45%, reflects higher capex spend ($171m in Q3), given an average realised Q3 price of $85/bbl, directly in line with our estimate for H2. Capex guidance for 2014 has been increased to $600m from $500m previously, with a further c.$100m outflow for exploration. $2.0bn in capex is now guided over the period 2014 – 2016, up from $1.5bn previously. While much of the latter reflects increased exploration activity, we would stress that the higher spend in Cheleken is recouped through the PSA. The gradual roll-out of the water injection programme and installation of jet pumps continues to elicit favourable commentary, even if hard data on the impact of the programme is largely absent. The intention now is to add electrical submersible pumps to those programmes in H2’15. There is no update on the distribution arrangement with Socar, which expires at the end of the year, and limited incremental commentary on the Petroceltic approach. As expected, confirmation on annual production growth guidance in the range of 10% - 15%, and target production of 100 kbopd by 2015 is re-affirmed. We would add that just five of the six new development wells brought on stream in Q3 were on production, the sixth being suspended. Despite that, average production achieved in September was 82.5 kbopd (previously outlined) proving a degree of confidence in the guided exit rate for the year of 87 – 90 kbopd. On balance, with much of the positive newsflow in terms of production growth outlined on Friday, data points of note are limited. That said, the rising cash pile, despite a dividend yield of almost 5%, continues to demonstrate the cash generative nature of Dragon’s Caspian Sea asset. Home… Page 2 14 Oct. 14 Recommendation: Buy Closing Price: £5.38 Gerry Hennigan +353-1-641 9274 gerry.f.hennigan@goodbody.ie Goodbody Morning Wrap Economic View Modestly expansionary budget likely to be announced today Irish fiscal policy has proved in the past to be a contributory factor to boom-bust episodes in the Irish economy. Electoral cycles had a big role to play in this and with the next general election in two years’ time, there was always a risk that Budget 2015 and 2016 was going to Dermot O’Leary +353-1-641 9167 dermot.c.oleary@goodbody.ie be more about political gains than economics. Latest reports suggest that the Minister is stretching prudence in the Budget 2015 package to be announced at 2.30pm today, although the 3% budget deficit target will still be achieved. As is often the case in Ireland, most of the major details of the budget have already been leaked at this stage. There will targeted spending measures announced in the areas of social housing and education. On the taxes side, the top rate of tax is likely to be cut by 1% while there may also be changes to the universal social charge. Important announcements are also expected in relation to the corporation tax regime. Following the recent furore over water charges, some form of tax relief is likely to be announced on this front. While we have been advocating a neutral budget, which in our view would allow the budget to fall to 2.1% of GDP next year, it is clear that Budget 2015 will be modestly expansionary. According to the Irish Times, the Budget will contain fiscal easing of €1bn in total, with €500m in tax measures and €500m in spending increases. With a 2.7% of GDP target, the Government cannot be accused of being reckless, but our preference would have been to make further progress towards a primary surplus that would put the debt on a steadier downward trajectory. Moreover, the clamour for higher spending and tax cuts is only likely to get louder in Budget 2016. Home… UK Economic View BRC retail sales disappoint in September BRC retail sales disappointed in September with like-for-like values falling by 2.1% yoy versus expectations of a 1% yoy increase. This is the largest decrease since April 2013. In total, retail sales values fell 0.8% yoy. In line with recent trends, the weakness is driven by food sales, which in total fell 1.7% yoy, while the non-food sector rose 3% yoy. However, the BRC also noted weakness in Clothing & Footwear sales with the unseasonably warm weather weighing on sales of autumn and winter clothing. The recovery in consumer spending in the UK has been underpinned by the strength of the labour market which is expected to continue. However, the very competitive landscape in the supermarket sector is likely to continue to have a negative impact on the value of food sales. Home… Page 3 14 Oct. 14 Juliet Tennent +353-1-641 9469 juliet.c.tennent@goodbody.ie Goodbody Morning Wrap PetroNeft Update on Drilling activity PetroNeft provided an update this morning on drilling activity in Siberia in which it outlined Recommendation: Buy that the vertical section of the T-5 well on the Tungolskoye field has been completed ahead Closing Price: £0.06 of scheduled drilling of the horizontal section. 8.2m of net oil pay was encountered, which flowed at a rate of 100 bopd. Post completion of the horizontal section, which is likely to take 3 – 4 weeks, PetroNeft hopes to achieve a much higher flow rate. Assuming a successful outcome, it is anticipated that the well can be brought into production in December / January Gerry Hennigan +353-1-641 9274 gerry.f.hennigan@goodbody.ie once winter roads are in place. Separately, drilling has commenced on the first new production well on the Arbuzovskoye field, a process that is expected to complete by the end of the month. In total, the schedule of activity calls for 3 to 5 wells to be brought on stream over the coming months. The recommencement of drilling activity by PetroNeft reflects an easing of funding restrictions post the farm-down to Oil India. The challenge now is to demonstrate that management can lift production towards licence processing capacity of c.14 kbopd. Home… Builders Merchants Carpetright / Bellway point to robust activity levels in the UK Carpetright has released a trading update for the 11 weeks to October 11th. Lfl sales in the UK have increased by 7% yoy compared to 6% in the 13 weeks to July. In the European business, which includes Ireland, Belgium and the Netherlands, the trend in lfl’s has also improved coming in at -0.5% in the last 11 weeks versus -3.5% in the 13 weeks earlier. Continued focus on promotional activity has driven strong sales growth in the UK and management notes that trading in Europe continues to improve particularly in the Netherlands. As a result, both the Dutch and Belgian businesses will be profitable in H1. In its FY14 results (July end), Bellway reported a 34% increase in sales (split H1 40%, H2 29%) which beat consensus by 1.3%. Pre-Tax profits are up 75% on last year and were 3% ahead of consensus. The company remains positive on the outlook for the UK with a record forward order book (+36% yoy) and expectations for 10% volume growth in 2015 (21% 2014, split 25% H1 / 18% H2). Overall, the updates from both Carpetright and Bellway point to robust trends in the UK, albeit at more mature rates of growth, all of which has a positive read through for Grafton, Howden Joinery, SIG and Travis Perkins. Indeed, we get the first direct update on the sector from Travis Perkins on Friday when it issues a Q3 IMS. Home… Page 4 14 Oct. 14 Robert Eason +353-1-641 9271 robert.v.eason@goodbody.ie David O’Brien +353-1-641 9230 david.a.o’brien@goodbody.ie Sarah Reilly +353-1-641 6080 sarah.k.reilly@goodbody.ie Goodbody Morning Wrap Wolseley Kesko highlights difficult markets in Finland Kesko has reported that sales in its Finnish Building Materials distribution business (No.1 player ahead of Wolseley) declined by 3% in September. As there was one extra trading day, we estimate the underlying figure was nearer c.7%, representing the third consecutive month of decline. In the recent results presentation, Wolseley’s management noted the challenging Recommendation: Buy Closing Price: £31.48 Robert Eason +353-1-641 9271 robert.v.eason@goodbody.ie backdrop in Finland (3-4% of group sales), while trends were more positive in Denmark and Sweden (6-7% and 3-4% of group sales, respectively). As a result, Wolseley’s management expects lfl sales to be slightly positive in the Nordics, which is consistent with our estimates. Home… SIG Further disposal of non-core assets SIG has announced this morning that it has disposed of ICE Energy, a specialist designer and Recommendation: Buy installer of ground source heat pumps and solar PV systems. This business has faced difficult Closing Price: £1.47 market conditions following a disappointing uptake of the UK Government’s Renewable Heat Incentive Scheme. The consideration for the divestment is a nominal cash payment of £1, with a potential earnout of up to £5m, dependent on performance to Mar-19. In addition, SIG is providing a £0.85m interest bearing loan, payable in 5 years. The disposal will lead to an exceptional charge of £8m (£1m cash), of which £3.3m was recognised in H114. The disposal of ICE Energy follows a similar announcement in the first half that it had sold Miller Pattison, another non-core asset. This will allow the group to focus solely on its core distribution businesses. Home… Page 5 14 Oct. 14 Robert Eason +353-1-641 9271 robert.v.eason@goodbody.ie Goodbody Morning Wrap C & C Group SABMiller sees Europe weaker in Q2 SABMiller said it saw a 5% increase in its net producer revenue (NPR) in H1 to end September, though this slowed to 3% in Q2. Most of the growth was derived from developing regions. In Europe, NPR fell 2% in Q2 though was still positive for the half year. The UK saw strong growth (+11%) driven by sales of the Peroni Azzurro brand, while some of the continental markets were adversely impacted by poor peak summer weather. In the US, revenues increased by 2%, with growth in premium products, including its Reds (apple Recommendation: Hold Closing Price: €3.93 Liam Igoe +353-1-641 9450 liam.a.igoe@goodbody.ie flavour beer) and Smith & Forge Hard Cider brands offsetting weaker sales in some of the core beers. The update from SABMiller underscores the fact that the core beer markets for the big brands remain challenging, with growth coming from niche premium products, including cider. C&C reports its H115 results on 29 October in which we expect contrasting performance in the US (negative) and Ireland (improving) to be a highlight. Home… CPL Resources Positive trends in Morgan McKinley employment monitor Morgan McKinley released its monthly employment monitor for September today. Professional jobs available rose by 30% yoy while at the same time the number of candidates seeking jobs has fallen 23%. The squeeze has led to higher incidences of counter offers and increasing salaries. It is worth noting that it this is not just happening in a few sectors but is prevalent across all sectors “from finance to tech, engineering and HR”. The results of the employment monitor reinforce our positive view on CPL. We expect to see wage pressure to increase going forward following an extended period of low or no wage growth from employers. Home… Page 6 14 Oct. 14 Recommendation: Buy Closing Price: €6.80 Colm Foley +353-1-641 6042 colm.j.foley@goodbody.ie Goodbody Morning Wrap Market Data Top 10 Covered Companies Company AIB Group Price Mkt Cap (LC) (LCM) 1 Day 1 Week Absolute 1 Mth Relative to European Sector P/E Ytd 1 Day 1 Week 1 Mth Ytd 2014f 2015f 0.10 52,621 -3.8 -4.7 -12.2 -9.8 -3.8 -0.4 -6.0 -7.9 76.5 86.6 CRH 16.22 12,057 -1.3 -8.9 -12.6 -11.4 -1.3 -4.8 -6.4 -9.5 18.8 14.4 Wolseley 31.48 8,391 0.7 -4.0 -3.9 -8.1 0.5 -0.2 3.9 -1.2 17.0 14.2 6.74 9,332 -0.3 -10.5 -10.8 7.6 -0.3 -6.5 -4.5 9.8 17.9 13.4 52.41 9,214 0.2 -3.7 -5.8 3.8 0.2 0.6 0.9 5.9 18.9 17.0 Bank of Ireland 0.28 8,970 -1.1 -10.4 -13.7 9.9 -1.1 -6.3 -7.6 12.2 18.7 13.0 IAG 3.24 6,013 -0.4 -12.7 -13.3 -19.3 -0.4 -8.8 -7.2 -17.6 n/m n/m 13.40 5,296 -0.6 -8.7 -3.9 -12.8 -0.8 -5.1 3.8 -6.2 n/m n/m Tullow Oil 5.30 4,818 0.7 -12.9 -25.1 -38.1 0.3 -9.8 -18.1 -31.3 9.7 12.7 Mondi 9.66 4,690 1.0 -4.0 -9.1 -7.6 1.0 0.3 -2.7 -5.7 11.5 11.1 Ryanair Kerry Group easyJet ISEQ performance Indices Price 1 Day 1 Week 1 Mth Ytd 5,200 ISEQ % 4,462.65 -0.61 -7.37 -8.96 -1.69 5,100 FTSE 100 6,366.24 0.41 -3.01 -6.47 -5.67 DAX 30 8,812.43 0.27 -4.31 -8.69 -7.74 CAC 40 4,078.70 0.12 -4.85 -8.17 -5.06 4,700 FTSE Eurofirst 300 1,293.91 0.07 -4.17 -6.44 -1.71 4,600 Nasdaq 4,213.66 -1.46 -5.41 -7.75 0.89 S&P 500 1,874.74 -1.65 -4.58 -5.58 1.43 Dow Jones 16,321.07 -1.35 -3.95 -3.92 -1.54 Nikkei 225 15,300.55 - -3.72 -4.06 -6.08 Px 1 day Px 1 Week 5,000 4,900 4,800 4,500 4,400 4,300 4,200 Oct-13 Jan-14 Apr-14 Jul-14 Exchange Rates Px Dec13 Avg Ytd Stg/€ Current 0.790 0.788 0.785 0.832 0.811 US$/€ 1.268 1.263 1.257 1.378 1.351 CHF/€ JPY/€ STOXX 600 performance 1.208 1.210 1.213 1.225 1.218 350 136.132 136.253 137.222 144.829 139.424 345 340 Bonds 335 330 Yield 1 Day Yld 1 Wk Yld 1 Mth Yld 3 Mth 325 US 2 Yr 0.42 - -0.10 -0.14 -0.02 320 US 10 Yr 2.28 - -0.14 -0.33 -0.24 315 UK 2 Yr 0.53 -0.03 -0.10 -0.15 -0.30 UK 10 Yr 2.17 -0.05 -0.19 -0.36 -0.44 BD 2 Yr 310 -0.05 0.01 0.03 0.01 -0.06 BD 10 Yr 0.85 0.01 -0.01 -0.19 -0.35 Irish 10 Yr 1.71 0.02 0.06 -0.14 -0.59 Commodities % 1 day 5 day 1 Mth 1 Yr 88.89 -1.46 -2.72 -8.46 -20.12 Gasoline (NYM $/Gal) 2.26 -0.10 -2.72 -10.46 -15.47 Heat Oil (NYM $/Gal) 2.56 -0.13 -0.74 -6.70 -15.75 Nat.Gas 3.92 1.48 1.58 1.53 3.71 1,229.00 0.82 0.99 -0.20 -2.88 17.41 0.87 0.35 -6.60 -19.10 6,802.00 1.57 0.70 -0.79 -4.53 5.05 1.35 -0.49 0.55 -27.01 Gold $/oz Silver $/ozt Copper U$/MT Wheat $/BU Source : FactSet Page 7 14 Oct. 14 Jan-14 Apr-14 Jul-14 FTSE 250 performance Current Brent (ICE $/bbl) 305 Oct-13 17,000 16,500 16,000 15,500 15,000 14,500 Oct-13 Jan-14 Apr-14 Jul-14 Goodbody Morning Wrap Issuer & Analyst Disclosures Analyst Certification The named Research Analyst certifies that: (1) All of the views expressed in this research report accurately reflect my personal views about any and all of the subject securities and issuers. (2) No part of my remuneration was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by me in this report. Regulatory Information Goodbody Stockbrokers, trading as Goodbody, is regulated by the Central Bank of Ireland. Goodbody is a member of the Irish Stock Exchange and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. This publication has been approved by Goodbody Stockbrokers. The information has been taken from sources we believe to be reliable, we do not guarantee their accuracy or completeness and any such information may be incomplete or condensed. All opinions and estimates constitute best judgement at the time of publication and are subject to change without notice. The information, tools and material presented in this document are provided to you for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities. Conflicts of Interest Goodbody Stockbrokers has procedures and policies in place to identify and manage any potential conflicts of interest that arise in connection with its research business. Goodbody Stockbrokers’ analysts and other staff who are involved in the preparation and dissemination of research operate and have a management reporting line that is independent to its Corporate Finance business. Information barriers are in place between the Corporate Finance arm and the Research arm to ensure that any confidential and or price sensitive information is handled in an appropriate manner. Our Investment Research Conflicts of Interest Policy is available at Conflicts of Interest Investors should be aware, that, where appropriate, research may be disclosed to the issuer(s) in advance of publication in order to correct factual inaccuracies only and not to materially amend the research in any way. Goodbody Stockbrokers is satisfied that it has operational procedures in place, which ensure that such disclosures will not compromise the report’s objectivity. Goodbody Stockbrokers and its associated companies may from time to time perform investment banking or corporate finance services, including underwriting, managing or advising on a public offering for, or solicit business from any company recommended in this report. Goodbody Stockbrokers may have acted, in the past 12 months, as lead manager / co-lead manager in the securities of any company named in this report. Goodbody is corporate broker to Hibernia REIT plc and a joint bookrunner in relation to the current offer. Goodbody Stockbrokers acts as corporate broker to AIB Group, Datalex, FBD Holdings, First Derivatives, Grafton Group, Greencore, Hibernia REIT, ICG, Kingspan, Origin Enterprises, Paddy Power, UDG Healthcare, and UTV Media Goodbody Stockbrokers is a registered market maker in the majority of companies listed on the Irish Stock Exchange and their equivalent on the London Stock Exchange and may hold positions in any of the companies mentioned in this report from time to time. A complete list of the companies that Goodbody Stockbrokers makes a market in is available at Regulatory Disclosures Page 8 14 Oct. 14 Goodbody Morning Wrap Other disclosures We would like to inform you that Gerry Hennigan holds shares in PetroNeft We would like to inform you that Robert Eason holds shares in SIG A description of this company is available at Company Descriptions All prices used in this report are as at close of business of the previous working day unless otherwise indicated. A summary of our standard valuation methods are available at Valuation Methodologies A summary of share price recommendations and whether material investment banking services have been provided to these companies is available at Regulatory Disclosures Other important disclosures are available at Regulatory Disclosures Goodbody Stockbrokers updates its recommendations on a regular basis. A breakdown of all recommendations provided by Goodbody Stockbrokers is available at Regulatory Disclosures Where Goodbody Stockbrokers has provided investment banking services to an issuer, details of the proportion of buys, adds, reduces and sells attributed to that issuer will also be included. This is updated on a quarterly basis. The date on which stock recommendations were first released for all stocks mentioned in this report are available at http://www.goodbody.ie/research_disclosures/regulatorydisclosures/index.html. If a different recommendation has been made in the previous twelve months, this will also be disclosed here. Recommendation Definitions Goodbody Stockbrokers uses the terms “Buy”, “Sell” and “Hold. The term “Buy” means that the analyst expects the security to appreciate in excess of 10% over a twelve month period. The term “Sell” means that the security is expected to decline in excess of 10% over the next twelve months. The term “Hold” means that the analyst expects the security to neither appreciate more than 10%, or depreciate more than 10% over the next twelve months. On 26th November, 2012, the terms “Add” and “Reduce” were removed from the Recommendation Definitions and both were replaced with the “Hold” recommendation. Any Previous Recommendation that refers to either an “Add” means that the analyst expected the security to appreciate by up to 15% over a twelve month period. Any Previous Recommendation to “Reduce” means that the analyst expected the security to decline by up to 15% over the next twelve months. In the event that a stock is delisted the firm will automatically cease coverage. If however the firm ceases to cover a stock for any other reason the firm will disclose this fact. Distribution of research to clients of Goodbody Securities Inc (GSI) in the US GSI distributes third-party research produced by its affiliate, Goodbody Stockbrokers GSI is a member of FINRA and SIPC GSI does not act as a market-maker. This information was current as of the last business day of the month preceding the date of the report. An affiliate of GSI may have acted, in the past 12 months, as lead manager/co-lead manager of a publicly disclosed offer of the securities in this company. Investors should be aware that an affiliate of GSI may have provided investment banking or non-investment-banking services to, and received compensation from this company in the past 12 months or may provide such services in the next three months. The term investment banking services includes acting as broker as well as the provision of corporate finance services, such as underwriting and managing or advising on a public offer. All transactions by US persons involving securities of companies discussed in this report are to be effected through GSI. Disclaimer While all reasonable care has been taken in the production and dissemination of this report it is not to be relied upon in substitution for the exercise of independent judgement. Nothing in this report constitutes investment, legal, accounting or tax advice, or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, or otherwise constitutes a personal recommendation to you. Private customers having access, should not act upon it in anyway but should consult with their independent professional advisors. The price, value and income of certain investments may rise or may be subject to sudden and large falls in value. You may not recover the total amount originally invested. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities. All material presented in this report, unless specifically indicated otherwise is copyright to Goodbody Stockbrokers. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Goodbody Stockbrokers. Goodbody, Ballsbridge Park, Ballsbridge, Dublin 4, Ireland T (+353 1) 6670400 W www.goodbody.ie E research@goodbody.ie Page 9 14 Oct. 14
© Copyright 2024